Autophagy Opposes p53-Mediated Tumor Barrier to Facilitate Tumorigenesis in a Model of PALB2-Associated Hereditary Breast Cancer

被引:122
作者
Huo, Yanying [1 ,2 ]
Cai, Hong [1 ,2 ]
Teplova, Irina [1 ]
Bowman-Colin, Christian [6 ]
Chen, Guanghua [1 ]
Price, Sandy [1 ]
Barnard, Nicola [3 ]
Ganesan, Shridar [1 ,4 ]
Karantza, Vassiliki [1 ,4 ]
White, Eileen [1 ,5 ]
Xia, Bing [1 ,2 ]
机构
[1] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA
[2] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ USA
[3] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pathol, New Brunswick, NJ 08903 USA
[4] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08903 USA
[5] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA
[6] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA
关键词
BRCA2; DEFICIENCY; TP53; MUTATIONS; FANCONI-ANEMIA; PALB2; P53; INACTIVATION; DISRUPTION; BECLIN-1; PARTNER; PROTEIN;
D O I
10.1158/2159-8290.CD-13-0011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hereditary breast cancers stem from germline mutations in susceptibility genes such as BRCA1, BRCA2, and PALB2, whose products function in the DNA damage response and redox regulation. Autophagy is an intracellular waste disposal and stress mitigation mechanism important for alleviating oxidative stress and DNA damage response activation; it can either suppress or promote cancer, but its role in breast cancer is unknown. Here, we show that similar to Brca1 and Brca2, ablation of Palb2 in the mouse mammary gland resulted in tumor development with long latency, and the tumors harbored mutations in Trp53. Interestingly, impaired autophagy, due to monoallelic loss of the essential autophagy gene Becn1, reduced Palb2-associated mammary tumorigenesis in a Trp53-wild-type but not conditionally null background. These results indicate that, in the face of DNA damage and oxidative stress elicited by PALB2 loss, p53 is a barrier to cancer development, whereas autophagy facilitates cell survival and tumorigenesis. (C) 2013 AACR.
引用
收藏
页码:894 / 907
页数:14
相关论文
共 48 条
[1]   BRCA1 induces antioxidant gene expression and resistance to oxidative stress [J].
Bae, I ;
Fan, S ;
Meng, QH ;
Rih, JK ;
Kim, HJ ;
Kang, HJ ;
Xu, JW ;
Goldberg, ID ;
Jaiswal, AK ;
Rosen, EM .
CANCER RESEARCH, 2004, 64 (21) :7893-7909
[2]   Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression [J].
Bouwman, Peter ;
Drost, Rinske ;
Klijn, Christiaan ;
Pieterse, Mark ;
van der Gulden, Hanneke ;
Song, Ji-Ying ;
Szuhai, Karoly ;
Jonkers, Jos .
JOURNAL OF PATHOLOGY, 2011, 224 (01) :10-21
[3]   Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer [J].
Bowman-Colin, Christian ;
Xia, Bing ;
Bunting, Samuel ;
Klijn, Christiaan ;
Drost, Rinske ;
Bouwman, Peter ;
Fineman, Laura ;
Chen, Xixi ;
Culhane, Aedin C. ;
Cai, Hong ;
Rodig, Scott J. ;
Bronson, Roderick T. ;
Jonkers, Jos ;
Nussenzweig, Andre ;
Kanellopoulou, Chryssa ;
Livingston, David M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (21) :8632-8637
[4]   Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination [J].
Buisson, Remi ;
Dion-Cote, Anne-Marie ;
Coulombe, Yan ;
Launay, Helene ;
Cai, Hong ;
Stasiak, Alicja Z. ;
Stasiak, Andrzej ;
Xia, Bing ;
Masson, Jean-Yves .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2010, 17 (10) :1247-+
[5]   Contribution of Inherited Mutations in the BRCA2-Interacting Protein PALB2 to Familial Breast Cancer [J].
Casadei, Silvia ;
Norquist, Barbara M. ;
Walsh, Tom ;
Stray, Sunday ;
Mandell, Jessica B. ;
Lee, Ming K. ;
Stamatoyannopoulos, John A. ;
King, Mary-Claire .
CANCER RESEARCH, 2011, 71 (06) :2222-2229
[6]   Brca2 deficiency does not impair mammary epithelium development but promotes mammary adenocarcinoma formation in p53+/- mutant mice [J].
Cheung, AMY ;
Elia, A ;
Tsao, MS ;
Done, S ;
Wagner, KU ;
Hennighausen, L ;
Hakem, R ;
Mak, TW .
CANCER RESEARCH, 2004, 64 (06) :1959-1965
[7]  
Diaz-Cruz Edgar S, 2010, Breast Dis, V32, P85, DOI 10.3233/BD-2010-0308
[8]   A recurrent mutation in PALB2 in Finnish cancer families [J].
Erkko, Hannele ;
Xia, Bing ;
Nikkilae, Jenni ;
Schleutker, Johanna ;
Syrjaekoski, Kirsi ;
Mannermaa, Arto ;
Kallioniemi, Anne ;
Pylkas, Katri ;
Karppinen, Sanna-Maria ;
Rapakko, Katrin ;
Miron, Alexander ;
Sheng, Qing ;
Li, Guilan ;
Mattila, Henna ;
Bell, Daphne W. ;
Haber, Daniel A. ;
Grip, Mervi ;
Reiman, Mervi ;
Jukkola-Vuorinen, Arja ;
Mustonen, Aki ;
Kere, Juha ;
Aaltonen, Lauri A. ;
Kosma, Veli-Matti ;
Kataja, Vesa ;
Soini, Ylermi ;
Drapkin, Ronny I. ;
Livingston, David M. ;
Winqvist, Robert .
NATURE, 2007, 446 (7133) :316-319
[9]   Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects [J].
Evers, B. ;
Jonkers, J. .
ONCOGENE, 2006, 25 (43) :5885-5897
[10]  
Greenblatt MS, 2001, CANCER RES, V61, P4092